These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 18268159)
1. Buflomedil in peripheral arterial disease: trials and tribulations. Conte MS Circulation; 2008 Feb; 117(6):717-9. PubMed ID: 18268159 [No Abstract] [Full Text] [Related]
2. Oral buflomedil in the prevention of cardiovascular events in patients with peripheral arterial obstructive disease: a randomized, placebo-controlled, 4-year study. ; Leizorovicz A; Becker F Circulation; 2008 Feb; 117(6):816-22. PubMed ID: 18212283 [TBL] [Abstract][Full Text] [Related]
3. Letter by De Backer et al regarding article, "Oral buflomedil in the prevention of cardiovascular events in patients with peripheral arterial obstructive disease: a randomized, placebo-controlled, 4-year study". De Backer TL; Vander Stichele RH; Van Bortel LM Circulation; 2008 Sep; 118(10):e151. PubMed ID: 18765384 [No Abstract] [Full Text] [Related]
4. Control of hypertension in patients with peripheral artery disease. Clement DL Blood Press; 2006; 15(4):251-2. PubMed ID: 17078187 [No Abstract] [Full Text] [Related]
5. Anti-platelet therapy: is it all over in peripheral artery disease? Jaipersad AS; Silverman SH; Lip GY Thromb Haemost; 2010 Apr; 103(4):689-91. PubMed ID: 20174749 [No Abstract] [Full Text] [Related]
6. [Intermittent claudication: review of a disease of growing prevalence. II. Treatment]. Riambau V; Piñol C Med Clin (Barc); 1998 Feb; 110(6):220-7. PubMed ID: 9580403 [No Abstract] [Full Text] [Related]
7. [Beta-adrenergic blockade and peripheral arterial insufficiency]. Sørlie D Tidsskr Nor Laegeforen; 1995 Feb; 115(6):696-7. PubMed ID: 7900127 [No Abstract] [Full Text] [Related]
8. Intermittent claudication: a plea for guidelines for medical management. Powell JT Eur J Vasc Endovasc Surg; 2007 Apr; 33(4):451-2. PubMed ID: 17196850 [No Abstract] [Full Text] [Related]
9. Beta blockers for peripheral arterial disease. Paravastu SC; Mendonca DA; da Silva A Eur J Vasc Endovasc Surg; 2009 Jul; 38(1):66-70. PubMed ID: 19359199 [TBL] [Abstract][Full Text] [Related]
10. [Buflomedil in the treatment of chronic peripheral arterial diseases. Case contribution]. Visconti W; Grillo N Minerva Med; 1985 May; 76(19-20):945-53. PubMed ID: 3158842 [TBL] [Abstract][Full Text] [Related]
11. Comparison of safety and efficacy of buflomedil and naftidrofuryl in the treatment of intermittent claudication. Rosas G; Cerdeyra C; Lucas MA; Parano JR; Villa JJ Angiology; 1981 May; 32(5):291-7. PubMed ID: 7235299 [TBL] [Abstract][Full Text] [Related]
12. Effects of prostaglandin E1 and buflomedil on left ventricular function in patients with severe chronic occlusive arterial disease: a prospective, randomized, double-blind trial. Kölsch B; Mohr-Kahaly S; Wittlich N; Reeh U; Meyer J Am J Ther; 1997; 4(11-12):375-80. PubMed ID: 10423633 [TBL] [Abstract][Full Text] [Related]
14. Positive effect of oral buflomedil on exercise-induced haemorheological damage and on claudication distance in peripheral obliterative arterial disease patients. Forconi S; Pieragalli D; Acciavatti A; Del Bigo C; Galigani C; Ralli L; Guerrini M; Di Perri T J Int Med Res; 1984; 12(3):188-92. PubMed ID: 6734922 [No Abstract] [Full Text] [Related]
15. Anti-chlamydial antibiotic therapy for symptom improvement in peripheral artery disease: prospective evaluation of rifalazil effect on vascular symptoms of intermittent claudication and other endpoints in Chlamydia pneumoniae seropositive patients (PROVIDENCE-1). Jaff MR; Dale RA; Creager MA; Lipicky RJ; Constant J; Campbell LA; Hiatt WR Circulation; 2009 Jan; 119(3):452-8. PubMed ID: 19139383 [TBL] [Abstract][Full Text] [Related]
16. A review of long-term safety data with buflomedil. Bachand RT; Dubourg AY J Int Med Res; 1990; 18(3):245-52. PubMed ID: 2193838 [TBL] [Abstract][Full Text] [Related]